Market Overview

FBR Capital Initiates TherapeuticsMD At Outperform, Shares Jump

Share:
Related
15 Stocks With The Highest Forecast Sales Growth
18 Biggest Mid-Day Gainers For Tuesday

FBR Capital Markets initiated coverage on shares of TherapeuticsMD (NYSE: TXMD) with an “outperform” rating.

The target price for TherapeuticsMD is set to $34.

TherapeuticsMD shares have jumped 54.10% over the past 52 weeks, while the S&P 500 index has gained 19.69% in the same period.

TherapeuticsMD's shares jumped 32.93% to $5.49 in pre-market trading.

Latest Ratings for TXMD

DateFirmActionFromTo
Dec 2016Cantor FitzgeraldInitiates Coverage OnOverweight
Dec 2016Stifel NicolausMaintainsBuy
Nov 2016OppenheimerInitiates Coverage OnOutperform

View More Analyst Ratings for TXMD
View the Latest Analyst Ratings

Posted-In: FBR Capital MarketsInitiation Analyst Ratings

 

Related Articles (TXMD)

View Comments and Join the Discussion!